GENE ONLINE|News &
Opinion
Blog

Funding
Pacific Biosciences Secures 900 Million Investment to Advance Gene Sequencing
2021-02-13
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Israeli Startup Raises $40 Million in Series B to Develop Cures for Food Allergies
2021-02-01
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy
2021-01-15
Philadelphia Based Biopharma Raises $88 Million in Series A Financing
2021-01-07
Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies
2021-01-06
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29Partner
Putting the Bio in Canadian Biomanufacturing
2020-12-25
Neuron23 Emerges from Stealth with $113.5 Million Financing
2020-12-18
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
SK Holdings Supports Roivant’s New Protein Degradation Platform with US$ 200 Million Investment
2020-12-13
Genesis Bags $52M Series A to Employ AI for Drug Discovery and Development
2020-12-06
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Ginkgo Receives $1.1B from the US Government to Fight Pandemics
2020-11-29
1 7 8 9 10 11
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top